Myo-inositol: with or without

Abstract

An innovative study by Heimark et al. [1] gives us the opportunity to clarify the debated role of myo-inositol (MI) and D-chiro-inositol (DCI) in Polycystic ovary syndrome (PCOS), an endocrine disorder in women (5 to 12%) and a leading cause of infertility. We integrate their findings with the study by Unfer et al. [2] focused on the same topic.